news
Allergan and AstraZeneca team up to develop ATM-AVI
29 January 2016 | By Victoria White
Allergan and AstraZeneca are to develop and commercialise ATM-AVI, an investigational, fixed-dose antibiotic combining aztreonam and avibactam...
List view / Grid view
Antibiotics
article
European Pharmaceutical Review’s top 10 stories from 2015
Mega mergers, 3D printed drugs, a call for action on antimicrobial resistance: 2015 certainly was an interesting year for the pharmaceutical industry. Here we pick a selection of the top stories that hit the headlines.
news
Pharma calls for collective action to combat antimicrobial resistance
21 January 2016 | By Victoria White
More than 80 companies and organisations have signed the Declaration on Combating Antimicrobial Resistance (AMR), an industry-wide call to action...
news
Existing drugs show promise as antibiotic agents
4 January 2016 | By Victoria White
University of Illinois researchers have found that a number of existing drugs approved for the treatment of various conditions, such as cancer or infertility, show promise as antibiotic agents...
news
EUCAST researches new critical breakpoints for antimicrobial agents
7 December 2015 | By Victoria White
Breakpoints of new agents are absolutely vital in standardising a global definition of resistance and the point at which increased dosages are needed...
news
ECDC survey shows increasing threat of antibiotic resistance
18 November 2015 | By Victoria White
Survey results released by the ECDC show that the situation continues to worsen with regard to the spread of CPE in the EU, with 3 countries reporting an endemic situation...
news
ESCMID highlights projects in the fight against antimicrobial resistance
13 November 2015 | By Victoria White
Ahead of the European Antibiotic Awareness Day, ESCMID has highlighted two of its more recent projects in the fight against antimicrobial resistance...
news
Research reveals antibiotic prescriptions are rising in the most deprived areas
12 November 2015 | By Victoria White
The data reveals antibiotic prescribing hotspots and interesting correlations against areas of deprivation. It also shows seasonal variation in antibiotic prescribing...
news
Coulter Partners recruits two to Curetis NV Supervisory Board
3 November 2015 | By Coulter Partners
Coulter Partners was delighted to partner with German diagnostics company Curetis AG on two strategic supervisory board appointments and congratulates them on their recent IPO launch...
news
NICE tackles overuse of antibiotics
18 August 2015 | By Victoria White
NICE, the UK health watchdog, has published guidance to help doctors, nurses and pharmacists promote and monitor the sensible use of antibiotics...
news
Antibiotic resistance poorly communicated and widely misunderstood
31 July 2015 | By Victoria White
People in the UK have little awareness of what ‘antibiotic resistance’ means, according to new research commissioned by the Wellcome Trust...
news
Phase I clinical trial of oral formulation of MGB-BP-3 for treatment of Clostridium Difficile infections begins
21 July 2015 | By Victoria White
The first group of healthy volunteers have been dosed in a Phase I clinical trial assessing the safety and tolerability of an oral formulation of MGB-BP-3...
news
FDA QIDP designation for Motif’s iclaprim for HABP
20 July 2015 | By Victoria White
The US FDA has designated Motif Bio's iclaprim as a Qualified Infectious Diseases Product (QIDP) for hospital acquired bacterial pneumonia (HABP)...
news
Scientists find new streptococcus variant causing severe infections
15 July 2015 | By Victoria White
Scientists have discovered a new subtype of emm89 streptococcus that has contributed to a rise in disease cases in the UK over the last 17 years...
news
UK leads Europe in antimicrobial point-of-care diagnostics research
2 July 2015 | By Victoria White
The UK takes the lead position when it comes to patent filings for antimicrobial point-of-care diagnostics in Europe...
